Treace Medical Concepts, Inc. (TMCI)
2.66
-0.11
(-3.97%)
USD |
NASDAQ |
May 15, 16:00
2.655
0.00 (0.00%)
After-Hours: 20:00
Treace Medical Concepts EPS Diluted (Quarterly) : -0.2781 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| UFP Technologies, Inc. | 2.243 |
| Owlet, Inc. | -0.1491 |
| Abbott Laboratories | 0.6165 |
| AngioDynamics, Inc. | -0.1944 |
| Accuray, Inc. | -0.095 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.96M |
| Revenue (Quarterly) | 47.20M |
| Total Expenses (Quarterly) | 65.16M |
| Enterprise Value | 192.31M |
| Gross Profit Margin (Quarterly) | 79.26% |
| Profit Margin (Quarterly) | -38.05% |
| Earnings Yield | -36.00% |
| Normalized Earnings Yield | -34.88 |